Cerebrolysin
Also known as: FPF-1070, porcine brain peptide preparation, EVER Neuro Pharma brain extract
Neurotrophic peptide mixture studied for stroke, traumatic brain injury, and cognitive support; mimics BDNF and GDNF-like factors to support neuron survival. Given IV or IM. Clinical evidence is debated.
Pharmacokinetics
Research only · no verified human PK. The values below are class estimates, not measured data, and this peptide is excluded from the Lab serum-level simulator.
- Half-life
- 30 min
- Time to peak
- 30 min
- Bioavailability
- 80%
Administration
- Primary routes
- IV, IM
- Category
- Neurological
Safety Flags
- High immunogenicity
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 2 outcome protocols
- NeuroprotectionPrimary
Protect and regenerate neural tissue for brain health
Safe default: 20mL · daily, 5 days/week for 4 weeks (clinical) · IV
- Memory Management
Enhance cognitive function and memory formation
Safe default: 10mL · daily, 5 days/week for 4 weeks; repeat 2-4 cycles/year · IV
Simulate Cerebrolysin
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.